Administration of anti-CD40L antibody blocked HCC tumor growth enhancement by Bregs in vivo, blocked enhancement of HCC cell proliferation by Bregs in vitro and decreased IL-10 and TGF-β1 secretion while promoting an increase of TNFα secretion. The gene discussed is TNF; the disease is neoplasm.